Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial.
about
Lipid, blood pressure and kidney update 2013.Influence of ezetimibe on selected parameters of oxidative stress in rat liver subjected to ischemia/reperfusionHow can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study.Statin treatment in the elderly: how much do we know?
P2860
Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@ast
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@en
type
label
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@ast
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@en
prefLabel
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@ast
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@en
P2093
P2860
P356
P1476
Effectiveness and tolerability ...... pidemia: The EZE(STAT)2 trial.
@en
P2093
A Shekhar Pandey
Emmanouil Rampakakis
John S Sampalis
Stella Boukas
Stéphane Bissonnette
P2860
P304
P356
10.5114/AOMS.2011.25550
P577
2011-10-01T00:00:00Z